With more than 600 intermediates BASF develops, produces and markets the world’s largest portfolio of chemical products as diverse as that. The portfolio comprises top quality building blocks, reagents, solvents and protective groups for chemical synthesis in the pharmaceutical industry. It features an extensive range of chiral amines, alcohols, epoxides and acids that are marketed under the ChiPros® trademark. Furthermore our customers benefit from our extensive technology platform. BASF develops customized new intermediates targeted specifically at the pharmaceutical market and can support customer projects from early phases to commercial stage. A dedicated New Business Development team keeps a special focus on the pharmaceutical industry.

Reagents BASF's portfolio includes organic reagents, specialty bases as well as chiral amines facilitating reactions with high selectivity.  Solvents BASF produces solvents of highest quality that meet the specific needs of the pharmaceutical industry.  Building Blocks BASF's extensive expertise in biocatalysis enables us to manufacture a wide range of building blocks.   Protective Groups BASF offers a range of protective groups for your synthesis.   Extensive Technology Platform    The Top Quality Portfolio for the Pharma Industry! Global contact data    Dr. Martin Merger Phone: +49 621 60-44614 martin.merger@basf.com